Cargando…

Early markers of heart damage in systemic sclerosis: role of cardiac magnetic resonance with late gadolinium enhancement

Detalles Bibliográficos
Autores principales:	Lario, Chiara Valentina, Ferraris, Federica, Mussetto, Annalisa Balbo, Macera, Annalisa, Pellerito, Raffaele, Cirillo, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032549/ http://dx.doi.org/10.1186/1532-429X-18-S1-P271

Ejemplares similares

S-100 Immunohistochemical Positivity in Rhabdomyoma: An Underestimated Potential Diagnostic Pitfall in Routine Practice
por: Palicelli, Andrea, et al.
Publicado: (2022)

Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis
por: Sano, Makoto, et al.
Publicado: (2014)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
por: Schelbert, Erik B., et al.
Publicado: (2017)

Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging
por: Huang, Y. Jessica, et al.
Publicado: (2016)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Is Associated With Subsequent Hospitalization for Heart Failure
por: Wong, Timothy C., et al.
Publicado: (2013)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Prognostic impact of late gadolinium enhancement cardiac magnetic resonance in the risk stratification of heart transplant patients
por: Pedrotti, Patrizia, et al.
Publicado: (2016)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

3D whole-heart grey-blood late gadolinium enhancement cardiovascular magnetic resonance imaging
por: Milotta, Giorgia, et al.
Publicado: (2021)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008)

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
por: Lopez, Javier E, et al.
Publicado: (2009)

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
por: Quail, Michael, et al.
Publicado: (2019)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Myocardial late gadolinium enhancement in systemic lupus erythematosus as a marker of chronic inflammation
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Diagnostic value of gadolinium contrast administration for spinal cord magnetic resonance imaging in multiple sclerosis patients and correlative markers of lesion enhancement
por: Karimian-Jazi, Kianush, et al.
Publicado: (2021)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
por: Kirk, Paul, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2012)

A comparison of late gadolinium enhancement magnetic resonance imaging and left atrial endocardial voltage
por: Harrison, James, et al.
Publicado: (2013)

Prediction of gaps in atrial ablation lesion sets by late gadolinium enhancement magnetic resonance imaging
por: Harrison, James, et al.
Publicado: (2013)

Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy
por: Ganigara, Madhusudan, et al.
Publicado: (2016)

Late gadolinium enhancement by cardiovascular magnetic resonance provides prognostic information in symptomatic alcoholic cardiomyopathy
por: Xiangli, Wei
Publicado: (2015)

Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar
por: Fahmy, Ahmed S., et al.
Publicado: (2018)

Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
por: Erley, Jennifer, et al.
Publicado: (2019)

Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes
por: Domenech-Ximenos, B., et al.
Publicado: (2020)

Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
por: Whitaker, John, et al.
Publicado: (2021)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
por: Gangadharakaimal, Harikrishnan, et al.
Publicado: (2023)

Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy
por: Zhang, Qiang, et al.
Publicado: (2021)

Myocardial tissue characterisation with late gadolinium enhancement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis
por: Ntusi, Ntobeko A, et al.
Publicado: (2013)

SWI enhances vein detection using gadolinium in multiple sclerosis
por: Maggi, Pietro, et al.
Publicado: (2015)

Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis
por: Voortman, MM, et al.
Publicado: (2017)

Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers
por: Giglio, Vincenzo, et al.
Publicado: (2014)

Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis
por: Solana, Elisabeth, et al.
Publicado: (2018)

The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images
por: Naruse, Yoshihisa, et al.
Publicado: (2011)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kien5lipk54fnd8us8nkho0iqq